Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man

Critical Care Medicine

Volumn 24, Issue 7, 1996, Pages 1150-1156

  Richer, Monique ^a   Robert, Sylvie ^b   Lebel, Marcel ^c  

^a UNIVERSITÉ LAVAL   (Canada)

^b PFIZER INC   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

catecholamines; critical illness; dopamine; electrolytes; glomerular filtration rate; hemodynamics; kidney; norepinephrine; renal blood flow, effective; urine

Indexed keywords

4 AMINOHIPPURIC ACID; CATECHOLAMINE; DOPAMINE; ELECTROLYTE; INULIN; NORADRENALIN; REVIMINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN EXPERIMENT; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SINGLE BLIND PROCEDURE; URINE VOLUME;

ADULT; BLOOD PRESSURE; DOPAMINE; ELECTROLYTES; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NOREPINEPHRINE; RANDOM ALLOCATION; RENAL CIRCULATION; VASOCONSTRICTOR AGENTS;

EID: 0029887192     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199607000-00014     Document Type: Article

References (47)

1. Zaritsky AL: Catecholamines, inotropic medications, and vasopressor agents. In: The Pharmacologic Approach to the Critically Ill Patient. Third Edition. Chernow B (Ed). Baltimore, Williams & Wilkins, 1994, pp 387-404
2. Califf RM, Bengston JR: Cardiogenic shock. N Engl J Med 1994; 330: 1724-1730
3. Hoffman BB, Lefkowitz RJ: Catecholamines and sympathomimetic drugs. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Eighth Edition. Goodman LS, Gilman A, Rall TW, et al (Eds). New York, Pergamon Press, 1990, pp 187-220
4. Schwartz LB, Gewertz BL: The renal response to low dose dopamine. J Surg Res 1988; 45:564-588
5. Felder RA, Felder CC, Eisner GM, et al: The dopamine receptor in adult and maturing kidney. Am J Physiol 1989; 257:F315-F327
6. Carey RM, Siragy HM, Felder RA: Physiological modulation of renal function by the renal dopaminergic system. J Auton Pharmacol 1990; 10(Suppl 1):S47-S51
7. 2-receptor activation inhibits noradrenaline release in human kidney slices. Kidney Int 1993; 43:197-204
8. Duke GJ, Bersten AD: Dopamine and renal salvage in the critically ill patient. Anaesth Intensive Care 1992; 20:277-302
9. Lebel M, Grose JH, Falardeau P: Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in man. Prostaglandins Leukot Essent Fatty Acids 1989; 35:41-49
10. D'Orio V, El Allaf D, Juchmès J, et al: The use of low doses of dopamine in intensive care medicine. Arch Int Physiol Biochim Biophys 1984; 92: S11-S20
11. Goldberg LI: Dopamine and new dopamine analogs: Receptors and clinical applications. J Clin Anesth 1988; 1: 66-74
12. Schaer GL, Fink MP, Parrillo JE: Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 1985; 13:492-496
13. Stringle TR, Petrinec D: The effect of renal range dopamine and norepinephrine infusions on the renal vasculature. Am Surg 1990; 56:494-496
14. Bersten AD, Rutten AJ: Renovascular interaction of epinephrine, dopamine and intraperitoneal sepsis. Crit Care Med 1995; 23:537-544
15. Conte G, Dal Canton A, Sabbatini M, et al: Acute cyclosporin renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 1989; 36:1086-1092
16. Kho TL, Teule J, Leunissen KML, et al: Nephrotoxic effect of cyclosporin A can be reversed by dopamine. Transplant Proc 1987; 19:1749-1753
17. Myles PS, Buckland MR, Schenk NJ, et al: Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 1993; 21:56-61
18. Weber DR: Is heparin really necessary in the lock and, if so, how much? DICP Ann Pharmacother 1991; 25:399-407
19. Du Bois D, Du Bois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17:863-871
20. Robert S, Perreault MM: Nouvelle méthode de détermination des clairances à l'inuline et à l'acide para-aminohippurique basée sur des données pharmacocinétiques. Abstr. Médecine Sciences 1994; 10(Suppl 1):21
21. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41
22. Dworkin LD, Brenner BM: The renal circulation. In: The Kidney. Fourth Edition. Brenner BM, Rector FC (Eds). Philadelphia, WB Saunders, 1991, pp 164-204
23. Heyrovski A: A new method for the determination of inulin in plasma and urine. Clin Chim Acta 1956; 1:470-474
24. Brun C: A rapid method for the determination of para-aminohippuric acid in kidney function tests. J Lab Clin Med 1951; 37:955-958
25. Rowland M, Tozer TN: Clinical Pharmacokinetics: Concepts and Application. Second Edition. Philadelphia, Lea & Febiger, 1989, pp 63-77
26. Isenring P, Lebel M, Falardeau P, et al: Eicosanoid modulation of the vasoconstrictor effect of norepinephrine on renal hemodynamics in man. Prostaglandins Leukot Essent Fatty Acids 1996; 54:59-63
27. Smythe CMcC, Nickel JF, Bradley SE: The effect of epinephrine (USP), l-epinephrine, and l-norepinephrine on glomerular filtration rate, renal plasma flow, and the urinary excretion of sodium, potassium and water in normal man. J Clin Invest 1952; 31:499-506
28. ter Wee P, Smit AJ, Rosman JB, et al: Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 1986; 6: 42-46
29. Abrahamsen AM, Storstein L, Westlie L, et al: Effects of dopamine on hemodynamics and renal function. Acta Med Scand 1974; 195:365-373
30. Graves TA, Cioffi WG, Vaughan GM, et al: The renal effects of low-dose dopamine in thermally injured patients. J Trauma 1993; 35:97-103
31. Hollenberg NK, Adams DF, Mendell P, et al: Renal vascular response to dopamine: Haemodynamic and angiographic observations in normal man. Clin Sci Mol Med 1973; 45:733-742
32. Schwartz LB, Bissell MG, Murphy M, et al: Renal effects of dopamine in vascular patients. J Vasc Surg 1988; 8: 367-374
33. Maddox DA, Brenner BM: Glomerular ultrafiltration. In: The Kidney. Fourth Edition. Brenner BM, Rector FC (Eds). Philadelphia, WB Saunders, 1991, pp 205-244
34. Navar LG, Gilmore JP, Joyner WL, et al: Direct assessment of renal microcirculatory dynamics. Federation Proc 1986; 45:2851-2861
35. Olsen NV, Lund J, Jensen PF, et al: Dopamine, dobutamine and dopexamine. A comparison of renal effects in unanesthetized human volunteers. Anesthesiology 1993; 79:685-694
36. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
37. Desjars P, Finaud M, Potel G, et al: A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987; 15:134-137
38. Martin C, Eon B, Saux P, et al: Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18:282-285
39. Fukuoka T, Nishimura M, Imanaka H, et al: Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels. Crit Care Med 1989; 17:1104-1107
40. Flancbaum L, Choban PS, Dasta JF: Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994; 22:61-66
41. Duke GJ, Briedes JH, Weaver RA: Renal support in critically ill patients: Low-dose dopamine or low-dose dobutamine? Crit Care Med 1994; 22: 1919-1925
42. Baldwin L, Henderson A, Hickman P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994; 120:744-747
43. Redl-Wenzl EM, Armbruster C, Edelman G, et al: The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19:151-154
44. Durkin RJ, Winter SM: Reversal of hepatorenal syndrome with the combination of norepinephrine and dopamine. Crit Care Med 1995; 23:202-203
45. Meyer MB, McNay JL, Goldberg LI: Effects of dopamine on renal function and hemodynamics in the dog. J Pharmacol Exp Ther 1967; 156:186-189
46. Rosenblum R, Tai AR, Lawson D: Cardiac and renal hemodynamic effects of dopamine in man. Abstr. Clin Res 1970; 18:326
47. Berg KJ, Bergan A: Effects of different doses of acetylsalicylic acid on renal function in the dog. Scand J Clin Lab Invest 1976; 36:779-786